Tags

Type your tag names separated by a space and hit enter

Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience.
Ann Rheum Dis. 2020 Jul 30 [Online ahead of print]AR

Authors+Show Affiliations

Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK asim.khan7@nhs.net.Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK.Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK.Critical Care Department, North Middlesex University Hospital NHS Trust, London, UK.Pharmacy Department, North Middlesex University Hospital NHS Trust, London, UK.Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK.Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK.Rheumatology Department, University College London Hospitals NHS Foundation Trust, London, UK.Critical Care Department, North Middlesex University Hospital NHS Trust, London, UK.Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK.

Pub Type(s)

Letter

Language

eng

PubMed ID

32732244

Citation

Khan, Asim, et al. "Correspondence On 'Characteristics Associated With Hospitalisation for COVID-19 in People With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician-reported Registry' By Gianfrancesco Et Al. Compassionate Use of Tocilizumab in Severe COVID-19 With Hyperinflammation Prior to Advent of Clinical Trials - a Real-world District General Hospital Experience." Annals of the Rheumatic Diseases, 2020.
Khan A, Cole A, Bhadauria N, et al. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience. Ann Rheum Dis. 2020.
Khan, A., Cole, A., Bhadauria, N., El-Hassan, M., Abdulla, D., Axon, T., Fattah, Z., Manson, J. J., Moreno-Cuesta, J., & Mukerjee, D. (2020). Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-218528
Khan A, et al. Correspondence On 'Characteristics Associated With Hospitalisation for COVID-19 in People With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician-reported Registry' By Gianfrancesco Et Al. Compassionate Use of Tocilizumab in Severe COVID-19 With Hyperinflammation Prior to Advent of Clinical Trials - a Real-world District General Hospital Experience. Ann Rheum Dis. 2020 Jul 30; PubMed PMID: 32732244.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience. AU - Khan,Asim, AU - Cole,Alice, AU - Bhadauria,Naveen, AU - El-Hassan,Munzir, AU - Abdulla,Daud, AU - Axon,Thomas, AU - Fattah,Zozik, AU - Manson,Jessica J, AU - Moreno-Cuesta,Jeronimo, AU - Mukerjee,Dev, Y1 - 2020/07/30/ PY - 2020/07/21/received PY - 2020/07/22/accepted PY - 2020/8/1/pubmed PY - 2020/8/1/medline PY - 2020/8/1/entrez KW - antirheumatic agents KW - biological therapy KW - cytokines KW - epidemiology KW - inflammation JF - Annals of the rheumatic diseases JO - Ann. Rheum. Dis. SN - 1468-2060 UR - https://www.unboundmedicine.com/medline/citation/32732244/Correspondence_on_'Characteristics_associated_with_hospitalisation_for_COVID-19_in_people_with_rheumatic_disease:_data_from_the_COVID-19_Global_Rheumatology_Alliance_physician-reported_registry'_by_Gianfrancesco_et_al._Compassionate_use_of_tocilizumab_in_severe_COVID-19_with_hyperinflammation_prior_to_advent_of_clinical_trials_-_a_real-world_district_general_hospital_experience L2 - https://ard.bmj.com/lookup/pmidlookup?view=long&pmid=32732244 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.